Emcure Pharmaceuticals launches Poviztra, a weekly semaglutide injection for weight loss, in partnership with Novo Nordisk. Priced from ₹2,200 per week, it targets India's massive obesity market.
India is actively reshaping its trade policy with new FTAs. Explore the signed deals, ongoing talks, and the strategic impact on exports and the economy. Read more.
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
The Indian government is considering data exclusivity for pharma, a move that could delay cheap generic drugs, impact India's global edge, and affect medicine access. Read the full analysis.
The Indian government mandates a 500-meter distance between Jan Aushadhi Kendras in major cities to protect store viability and ensure access to affordable generic medicines. Learn about the new policy's impact.
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
India and Oman have unveiled a comprehensive joint vision document to enhance cooperation in trade, energy, maritime security, and people-to-people ties. Explore the key agreements shaping this strategic partnership.
The US Embassy in India highlights VP nominee JD Vance's praise for bilateral ties, calling India a friend. Explore the strategic importance and future of India-US relations.
Karnataka Health Minister Dinesh Gundu Rao announces state will appeal HC order quashing closure of Jan Aushadi Kendras in govt hospitals. Read the full story.
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
Senior US State Department official Allison Hooker and trade negotiators arrive in India to strengthen economic ties, discuss tariffs, and foster AI and space collaboration. Key meetings scheduled in New Delhi and Bengaluru.
India & Russia sign 16 pacts, chart roadmap till 2030. Key takeaways on labour mobility, trade, defence & nuclear energy. Essential analysis for UPSC aspirants on bilateral ties, repo rate, labour codes & more.
India and Russia deepen strategic ties, signing agreements in trade, energy, and tech, aiming for $100 billion trade by 2030. Can this offset US tariff pressures?
Delhi High Court rejects Novo Nordisk's plea for interim injunction against Dr Reddy's Labs over semaglutide. Court cites 'evergreening', allows DRL to export. Key ruling for diabetes drug market.
A recent Delhi High Court order in the Novo Nordisk vs Dr Reddy's case highlights the complexities of Indian patent litigation. We examine the system's challenges and the push for specialized IP courts.
Anna Haakenson's viral Instagram post details 9 cultural contrasts between India and the US after a 2.5-month family trip. Discover the insights sparking global discussion.
As Putin visits India, the world watches how New Delhi will balance discounted Russian oil, defence needs, and US pressure. Will India secure its autonomy or face new sanctions?
WHO releases its first global guideline on GLP-1 therapies for obesity, recommending drugs like semaglutide for adults with a BMI over 30. Learn about the impact, safety, and who can benefit.
Russian President Vladimir Putin aims to elevate cooperation with India to a new level during his Dec 4-5 visit. Defence deals like S-400, Su-57 jets & nuclear energy pacts to dominate talks.
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
India's tourism sector sees a strong recovery, with the US, UK, and Canada among the top contributors. Discover the full list and key insights from the latest 2024-25 data.
Novo Nordisk and Eli Lilly develop daily oral weight loss pills with 10-16% average weight loss in trials. Pending FDA approval, these could replace injections.
IMF's latest assessment reveals India's strong economic outlook with 6.6% growth forecast. Discover how prudent policies and structural reforms drive sustained growth and reduce poverty.
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.
Michelle Obama faces Ozempic rumors after revealing slimmer frame in Annie Leibovitz photoshoot. Social media erupts with speculation despite no evidence. Read the full story.
Discover 10 breathtaking Indian destinations that offer European winter charm without international travel. Perfect winter escapes with snow, architecture & alpine vibes.
India becomes OpenAI's second-largest market as American firms invest billions. Discover how India's 900M internet users are shaping the future of artificial intelligence.
Discover the top 6 lifestyle diseases affecting Indians, their causes, symptoms, and preventive measures. Learn how to protect your health today!
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Biocon's generics business surges 24% driven by weight-loss drugs liraglutide & semaglutide. CEO Siddharth Mittal reveals strategy to capture share of the booming $95 billion GLP-1 market.